课题基金 / 基金详情

Fas/FasL System In Normal Mammary Gland Development

Fas/FasL System In Normal Mammary Gland Development
正常乳腺发育中的 Fas/FasL 系统
批准号:
6634094
负责人:
GIL G MOR
金额:
$27.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2005-05-31

项目摘要

项目成果

GIL G MOR的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(由申请人提供)本提案回应
英文摘要
DESCRIPTION: (Provided by the applicant) This proposal responds to the programmatic priorities of RFA PA 99-162 "Stages of breast development: normal to metastatic disease." We propose to study the mechanism by which mammary development and involution regulate the development of breast cancer. It is our general hypothesis that programmed cell death (PCD) of mammary epithelial cells during involution is mediated by the FasIFasL system. Others and we have proposed that apoptosis associated with breast involution confers resistance to tumorigenesis while inappropriate survival of the secretory epithelial cells apparently increases susceptibility to tumor development. Accordingly, conditions that limit proliferation or cause breast epithelial cell death could result in reduction of risk for breast cancer in humans. Our data indicates that the expression of Fas receptor protein on the mammary cell surface triggers apoptosis at the end of lactation. Thus, alterations in the Fas/FasL system may regulate the survival of proliferating cells that have the potential for malignant transformation. It is our second hypothesis that breast cancer may arise from the failure of the FasIFasL apoptotic pathway that would normally eliminate aging or transformed cells that are at risk of malignant transformation. The absence of the Fasmediated-apoptotic signal results in the persistence of transformed cells expressing only FasL on their surface. To prove the validity of our hypothesis we propose a four-year plan to: 1) Study Fas and FasL expression in normal mouse mammary gland and its role in mammary gland development and remodeling. 2) Study the role of Fas and FasL in normal and pathologic mouse mammary gland development in Fas and FasL deficient mice. 3) To investigate the regulation of Fas and FasL expression and function; and 4) Study the regulation of FasL expression by estrogen and selective estrogen receptor modulators (SERMs). A thin line separates normal from neoplastic development. A delicate balance between cell growth and cell apoptosis maintains this homeostatic state. Once that line is breached the same genes protecting the organism from cancer may become involved in its genesis. The genes encoding Fas and FasL, which normally regulate homeostasis yet have the potential to foster malignant growth, exemplify' this tenuous balance. A more thorough understanding of the function and regulation of the genes involved in tissue homeostasis and tumor suppression will provide valuable information related to the biology and development of the normal mammary gland. With an improved foundation of the normal mammary physiology, we can advance the understanding of breast cancer, allowing the development of effective strategies for its treatment and prevention.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/1479-5876-5-6
发表时间: 2007-01-26
期刊: JOURNAL OF TRANSLATIONAL MEDICINE
影响因子: 7.4
作者: [Kluger, Harriet M., McCarthy, Mary M., Alvero, Ayesha B., Sznol, Mario, Ariyan, Stephan, Camp, Robert L., Rimm, David L., Mor, Gil]
通讯作者: Mor, Gil
Impact of benzene-induced MIA on fetal T cell development
  • 批准号:
    10605881
  • 项目类别:
  • 资助金额:
    $38.71万
  • 财政年份:
    2023
  • 负责人:
    GIL G MOR
  • 依托单位:
Impact of BTEX Chemical Exposure During Pregnancy to Maternal and Fetal Well-Being
  • 批准号:
    10352965
  • 项目类别:
  • 资助金额:
    $31.2万
  • 财政年份:
    2022
  • 负责人:
    GIL G MOR
  • 依托单位:
Impact of BTEX Chemical Exposure During Pregnancy to Maternal and Fetal Well-Being
  • 批准号:
    10700806
  • 项目类别:
  • 资助金额:
    $31.36万
  • 财政年份:
    2022
  • 负责人:
    GIL G MOR
  • 依托单位:
Mechanisms of trophoblast-induced immune modulation
  • 批准号:
    10226144
  • 项目类别:
  • 资助金额:
    $38.5万
  • 财政年份:
    2019
  • 负责人:
    GIL G MOR
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: